Literature DB >> 12500091

Increased S-nitrosothiols and S-nitrosoalbumin in cerebrospinal fluid after severe traumatic brain injury in infants and children: indirect association with intracranial pressure.

Hülya Bayir1, Patrick M Kochanek, Shang-Xi Liu, Antonio Arroyo, Anatoly Osipov, Jianfei Jiang, Stephan Wisniewski, P David Adelson, Steven H Graham, Valerian E Kagan.   

Abstract

Nitric oxide (NO) is implicated in both secondary damage and recovery after traumatic brain injury (TBI). Transfer of NO groups to cysteine sulfhydryls on proteins produces S-nitrosothiols (RSNO). S-nitrosothiols may be neuroprotective after TBI by nitrosylation of N-methyl-D-aspartate receptor and caspases. S-nitrosothiols release NO on decomposition for which endogenous reductants (i.e., ascorbate) are essential, and ascorbate is depleted in cerebrospinal fluid (CSF) after pediatric TBI. This study examined the presence and decomposition of RSNO in CSF and the association between CSF RSNO level and physiologic parameters after severe TBI. Cerebrospinal fluid samples (n = 72) were obtained from 18 infants and children on days 1 to 3 after severe TBI (Glasgow Coma Scale score < 8) and 18 controls. Cerebrospinal fluid RSNO levels assessed by fluorometric assay peaked on day 3 versus control (1.42 +/- 0.11 micromol/L vs. 0.86 +/- 0.04, P< 0.05). S-nitrosoalbumin levels were also higher after TBI (n = 8, 0.99 +/- 0.09 micromol/L on day 3 vs. n = 6, 0.42 +/- 0.02 in controls, P< 0.05). S-nitrosoalbumin decomposition was decreased after TBI. Multivariate analysis showed an inverse relation between CSF RSNO and intracranial pressure and a direct relation with barbiturate treatment. Using a novel assay, the presence of RSNO and S-nitrosoalbumin in human CSF, an approximately 1.7-fold increase after TBI, and an association with low intracranial pressure are reported, supporting a possible neuroprotective role for RSNO. The increase in RSNO may result from increased NO production and/or decreased RSNO decomposition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12500091     DOI: 10.1097/01.WCB.0000040399.30600.E3

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  6 in total

Review 1.  Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties.

Authors:  K Oettl; R E Stauber
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

2.  Cytoprotective effects of albumin, nitrosated or reduced, in cultured rat pulmonary vascular cells.

Authors:  Hui-Hua Li; Jing Xu; Karla J Wasserloos; Jin Li; Yulia Y Tyurina; Valerian E Kagan; Xiaorong Wang; Alex F Chen; Zhao-Qian Liu; Detcho Stoyanovsky; Bruce R Pitt; Li-Ming Zhang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-01-14       Impact factor: 5.464

3.  Detectable levels of cytochrome C and activated caspase-9 in cerebrospinal fluid after human traumatic brain injury.

Authors:  Ribal S Darwish; Nana S Amiridze
Journal:  Neurocrit Care       Date:  2010-06       Impact factor: 3.210

Review 4.  Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.

Authors:  Valerie C Besson
Journal:  Br J Pharmacol       Date:  2009-04-09       Impact factor: 8.739

Review 5.  Therapeutic hypothermia for traumatic brain injury.

Authors:  L A Urbano; Mauro Oddo
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

6.  Regulation of nerve growth and patterning by cell surface protein disulphide isomerase.

Authors:  Geoffrey Mw Cook; Catia Sousa; Julia Schaeffer; Katherine Wiles; Prem Jareonsettasin; Asanish Kalyanasundaram; Eleanor Walder; Catharina Casper; Serena Patel; Pei Wei Chua; Gioia Riboni-Verri; Mansoor Raza; Nol Swaddiwudhipong; Andrew Hui; Ameer Abdullah; Saj Wajed; Roger J Keynes
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.